Selective deficiency of hepatic triglyceride lipase in uremic patients
- PMID: 200841
- DOI: 10.1056/NEJM197712222972502
Selective deficiency of hepatic triglyceride lipase in uremic patients
Abstract
To investigate the pathogenesis of hypertriglyceridemia in patients with renal disease we measured plasma lipoprotein composition as well as hepatic triglyceride lipase and lipoprotein lipase in post-heparin plasma. Three groups with renal disease were studied: conservatively treated chronic uremia; patients undergoing maintenance hemodialysis; and renal-allograft recipients. A selective decrease of hepatic triglyceride lipase with normal lipoprotein lipase was found in conservatively treated uremia and in patients undergoing hemodialysis. Elevated levels of very-low-density lipoproteins and increased triglycerides in low-density lipoproteins occurred in these patients. In contrast, hepatic triglyceride lipase and lipoprotein lipase were both normal in patients after renal transplantation who had Type II hyperlipoproteinemia as a common lipoprotein pattern with increased low-density-lipoprotein cholesterol and decreased high-density-lipoprotein cholesterol concentrations. The accumulation of a triglyceride-rich low-density lipoprotein in the majority of patients with renal disease may be the consequence of low hepatic triglyceride lipase.
Similar articles
-
Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.Metabolism. 2003 Jan;52(1):116-21. doi: 10.1053/meta.2003.50018. Metabolism. 2003. PMID: 12524671 Clinical Trial.
-
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.N Engl J Med. 1979 Nov 15;301(20):1073-6. doi: 10.1056/NEJM197911153012001. N Engl J Med. 1979. PMID: 226883
-
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.Clin Nephrol. 1995 Apr;43(4):268-77. Clin Nephrol. 1995. PMID: 7606882 Clinical Trial.
-
[Features of hypertriglyceridemia in chronic kidney disease(CKD)].Nihon Rinsho. 2013 Sep;71(9):1618-22. Nihon Rinsho. 2013. PMID: 24205724 Review. Japanese.
-
Hyperlipoproteinemia in renal insufficiency.Nephron. 1980;25(1):1-7. doi: 10.1159/000181745. Nephron. 1980. PMID: 6986036 Review.
Cited by
-
[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].Klin Wochenschr. 1982 Apr 1;60(7):327-36. doi: 10.1007/BF01721622. Klin Wochenschr. 1982. PMID: 6122754 Review. German.
-
Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.PLoS One. 2016 Nov 18;11(11):e0166459. doi: 10.1371/journal.pone.0166459. eCollection 2016. PLoS One. 2016. PMID: 27861640 Free PMC article.
-
Role of the kidney in hormone metabolism and its implications in clinical medicine.Klin Wochenschr. 1980 Oct 1;58(19):1005-12. doi: 10.1007/BF01476870. Klin Wochenschr. 1980. PMID: 7005522 Review.
-
Accumulation of visceral fat in maintenance hemodialysis patients.Clin Exp Nephrol. 2012 Feb;16(1):156-63. doi: 10.1007/s10157-011-0544-8. Epub 2011 Oct 13. Clin Exp Nephrol. 2012. PMID: 21989558
-
Morphological changes of the liver in uremic patients treated with chronic hemodialysis--laparoscopic observations and light- and electron-microscopic studies.Gastroenterol Jpn. 1980;15(3):212-20. doi: 10.1007/BF02774270. Gastroenterol Jpn. 1980. PMID: 7399221
MeSH terms
Substances
LinkOut - more resources
Full Text Sources